Genomic Test Menu

Informed Consent Requirements

Informed Consent Form

Insurance Prior Authorization Information

ACMG Practice Guidelines

NCCN Guidelines, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic

NCCN Guidelines, Genetic/Familial High-Risk Assessment: Colorectal

Next generation sequencing panels 

Hereditary cancer genetic risk testing 

Print Request and Clinical History Form

Breast and ovarian cancer predisposition panels

BRCA1 and BRCA2 (BReast CAncer genes 1 and 2) Sequencing and Full Deletions/ Duplications
(includes full gene sequencing of BRCA1 and 2, with full gene (all exons) deletion/duplication by MLPA)

BRCA1 and BRCA2 (BReast CAncer genes 1 and 2) Full Deletion/ Duplication by MLPA
Hereditary Breast/Ovarian Cancer-Related Gene Sequence Analysis (19 genes)

Other cancer predisposition panels

Print Request and Clinical History Form

Hereditary Colorectal/HNPCC Cancer Risk Panel (15 genes)
Hereditary Endometrial Cancer Risk Panel (18 genes)
Hereditary Familial Cutaneous Melanoma Risk Panel (2 genes)
Hereditary Neuroendocrine Tumor Disorders Risk Panel (13 genes)
Customized Hereditary Cancer Testing (94 genes)

Inherited Disorders

Print Request Form

Cystic Fibrosis
SMA Carrier Screen
Thrombophilia Risk Panel

  • Prothrombin 20210 G -->A
  • Factor V (Leiden)
  • Methylenetetrahydrofolate reductase (MTHFR)

Fragile X Syndrome
Hereditary Hemochromatosis (HFE)
Familial Mediterranean Fever (FMF)
PGx - Cytochrome P450 2C19 (CYP2C19)

Hematolymphoid next generation sequencing multi-gene panel 

Hematolymphoid 51 Gene Panel
DeNovo AML Panel
Myeloproliferative Neoplasm (MPN) Panel

Print Request Form

RNA Tests (RT-PCR)

BCR-ABL t(9;22), p210 kD, M-bcr (major breakpoint)
BCR-ABL t(9;22), p190 kD, m-bcr (minor breakpoint)
PML-RARA t(15;17)
CBFb-MYH11 inv(16)

DNA single gene tests

JAK2 Mutation Analysis
Calreticulin (CALR) Mutation Analysis
NPM1 Mutation Analysis
FLT3 Mutation Analysis
B Cell (IGH) Gene Rearrangement
T Cell Receptor Gene Rearrangement (gamma and beta)
IDH1/2 Mutation Detection

Solid tumor next generation sequencing   

Print Request Form
Solid Tumor Sequencing Panel (48 Genes)
Colorectal Cancer Panel
Lung Cancer Panel
Melanoma Panel
Gastrointestinal Stromal Tumors Panel
Fusion Panel - Solid Tumor
Fusion Panel - Sarcoma
Comprehensive Solid Tumor Cancer Panel (170 genes)

Brain Tumors

1p/19q Loss of Heterozygosity
MGMT Promoter Methylation in Gliomas
EGFRvIII mutation in Gliomas
IDH1/2 Mutation Detection
BRAF Mutation Detection
Fusion Panel - Solid Tumor
Fusion Panel - Sarcoma

Lung Cancers-Colorectal Cancer-Lynch Syndrome-Melanoma

EGFR TKI Sensitivity and Resistance Mutations
KRAS mutation detection for Codon 12, 13, 61 and 146
NRAS Mutation Detection for Codons 12, 13 and 61
Microsatellite Instability (MSI) Testing, IHC, MLH1 - Lynch Syndrome
Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 protein expression
MLH1 Promoter Methylation Detection
BRAF Mutation Detection


Print Request Form

Gestational Disease Profile Tissue/Patient Identification by DNA Analysis (Non-paternity)
Epstein-Barr Virus (EBV) detection by in-situ hybridization
Kappa/Lambda detection by in-situ hybridization


Schedule Appointment Online

** Check with your insurance carrier for coverage limitations.

If you can't find a date/time that works for you please call the provider’s office. Not all appointment types at all locations are available online.

Henry Ford Health System is committed to ensuring our Deaf or hard-of-hearing patients and visitors have equal access to all services. We provide the appropriate auxiliary aids and services, including qualified sign language interpreters, TTYs and other assistive listening devices, at no cost. To request assistance, call 313-916-1896 or email

If you have traveled to China in the last 14 days or been in close contact with someone suspected to have the coronavirus, please contact our nurse line @ 313- 874-7500 prior to scheduling.

Schedule Appointment for